SCHEMBL5013483

SCHEMBL5013483

O=C(O)c1cc(NC(=O)c2cc(F)c(Cl)cc2Cl)[nH]n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR27 Q9NS67 1/20 0.44
PYGL P06737 2/20 0.43
ALPL P05186 4/20 0.43
STING1 Q86WV6 1/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
KEAP1 Q14145 1/20 0.39
NFE2L2 Q16236 1/20 0.39
POLB P06746 1/20 0.38
APEX1 P27695 1/20 0.38
NTRK1 P04629 1/20 0.38
CYTH3 O43739 1/20 0.38
BTK Q06187 1/20 0.38
EPN1 Q9Y6I3 1/20 0.38
ALOX15 P16050 1/20 0.38
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
HPGD P15428 1/20 0.38
ALDH1A1 P00352 1/20 0.37
TDP1 Q9NUW8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3822963 0.93 PYGL (0.50) PYGLNPC1RAB9APOLBAPEX1
SCHEMBL5013495 0.85 PYGL (0.44) PYGLNPC1RAB9APOLBAPEX1
SCHEMBL5012235 0.83 KEAP1 (0.59) PYGLSTING1KEAP1NFE2L2CYTH3
Imidazole SCHEMBL3820589 0.82 PYGL (0.42) PYGLNPC1RAB9APOLBAPEX1
SCHEMBL27706777 0.82 PYGL (0.37) GPR27PYGLNPC1RAB9AKEAP1
SCHEMBL3825349 0.81 HCAR2 (0.44) GPR27STING1NPC1RAB9ACYTH3
SCHEMBL5010377 0.81 CYTH3 (0.38) PYGLSTING1NPC1RAB9AKEAP1
SCHEMBL5012183 0.80 NPC1 (0.55) GPR27NPC1RAB9AKMT2AMEN1
SCHEMBL5010443 0.80 PPARG (0.56) PYGLALPLNPC1RAB9AALOX15
SCHEMBL5010442 0.79 NPC1 (0.49) PYGLALPLNPC1RAB9APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1884513-A1 PYRAZOLE COMPOUND AND THERAPEUTIC AGENT FOR DIABETES COMPRISING THE SAME Japan Tobacco, Inc. (JP) 2008-02-06 EP claimed
US-20070032529-A1 Pyrazole compounds and their use as antidiabetes agents JAPAN TOBACCO INC. (JP) 2007-02-08 US claimed
EP-1884513-A1 PYRAZOLE COMPOUND AND THERAPEUTIC AGENT FOR DIABETES COMPRISING THE SAME Japan Tobacco, Inc. (JP) 2008-02-06 EP disclosed
US-20070032529-A1 Pyrazole compounds and their use as antidiabetes agents JAPAN TOBACCO INC. (JP) 2007-02-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070032529-A1 Pyrazole compounds and their use as antidiabetes agents PYGL, GYS2, AGL GPR27 2178/4885PYGL 1/4885ALPL 101/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.